New drug tested to stop prostate Cancer's return after surgery
NCT ID NCT07444983
Summary
This study is testing if a new drug called Rezvilutamide, when added to standard hormone therapy, can help keep prostate cancer from coming back after surgery. It will involve about 33 men with high-risk prostate cancer who have had their prostate removed. The main goal is to see if this combination treatment lowers the chance of the cancer returning within three years and to check for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (ADENOCARCINOMA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Urology, Fujian Union Hospital, Fujian Medical University
Fuzhou, Fujian, 350000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.